ClinicalTrials.gg
Sign In

Cross Infection clinical trials

The registry lists 285 studies for Cross Infection across more than 10 countries. 48 are recruiting or about to start. 155 of them are mainly about Cross Infection (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-05. Counting its 2 narrower conditions too, such as Pneumonia, Ventilator-Associated: 743 studies, 139 open.

Get an email when these change. Save the Cross Infection studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
168
Status unknown
43
Recruiting
27
Not yet recruiting
17
Terminated
16
Active, not recruiting
9

Phase

Phase 3
26
Phase 2
22
Phase 4
19
Phase 1
8

Where

United States
60
France
47
Italy
15
Turkey
14
Canada
13
China
10

Who runs them

Assistance Publique - Hôpitaux de Paris (6) · Wyeth is now a wholly owned subsidiary of Pfizer (5) · University of Michigan (4) · Hospital Italiano de Buenos Aires (4) · Emory University (4) · University of Calgary (4) · University Hospital, Lille (4) · Hospices Civils de Lyon (4)

What is being tested here

Drugs under test in Cross Infection studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Baloxavir101
Oseltamivir101
Tigecycline045
Chlorhexidine004
Chlorhexidine gluconate003
Doripenem013
Lactobacillus reuteri022
Daptomycin022
Colistin012
Engerix-B001

Coming up

2phase 3 studies under way
14studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest

Who these studies take

Of the 27 Cross Infection studies recruiting now, 22 (81%) set no upper age limit and 3 (11%) stop at 75 or younger. 5 (19%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 6 (22%) take healthy volunteers.

Recruiting studies that take each age, of 27
AgeWomenMen
103 (11%)3 (11%)
1824 (89%)24 (89%)
3024 (89%)24 (89%)
4024 (89%)24 (89%)
5024 (89%)24 (89%)
6525 (93%)25 (93%)
7524 (89%)24 (89%)
8524 (89%)24 (89%)

Across all 285 studies, recruiting or not: 19% stop at 75 or younger and 16% at 65; 32% take children; 1% are for women only and 0% for men only; 19% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Cross Infection studies take

Of 59 interventional studies with no phase under Cross Infection, half reached primary completion within 16 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase16 mo6–29 · 59 studies—16 mo7–29 · 57 studies
Observational28 mo17–65 · 56 studies—28 mo17–65 · 56 studies

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 13, 2026.

Stopped1

Newly registered2

Studies

Recruiting first, then most recently updated. Showing 50 of 285. Browse all 285 → or search them.